RYR | Placebo | P-value | |
---|---|---|---|
Age (years), mean ± SD | 63 ± 8 | 64 ± 9 | 0.566 |
Male, n (%) | 17 | 23 | 0.475 |
Statin, n (%) | |||
Atorvastatin 10 mg | 3 | 7 | 0.671 |
Atorvastatin 20 mg | 16 | 14 | |
Atorvastatin 40 mg | 4 | 9 | |
Rosuvastatin 5 mg | 8 | 6 | |
Rosuvastatin 10 mg | 4 | 3 | |
Rosuvastatin 20 mg | 5 | 7 | |
Rosuvastatin 40 mg | 3 | 3 | |
TG (mg/dL), mean ± SD | 133.6 ± 68.3 | 117.3 ± 63.6 | 0.23 |
Total cholesterol (mg/dL), mean ± SD | 164.2 ± 34.4 | 147.1 ± 25 | 0.007 |
LDL cholesterol (mg/dL), mean ± SD | 100.9 ± 24.2 | 87.4 ± 20.8 | 0.005 |
HDL cholesterol (mg/dL), mean ± SD | 43.7 ± 10.1 | 42.6 ± 12.1 | 0.642 |
Hs-CRP (mg/dL), mean ± SD | 1.59 ± 2.3 | 1.4 ± 2.16 | 0.78 |
Daily calories intake (kcal/day) | 2340 ± 120 | 2297 ± 139 | 0.11 |